PATENT CLAIM ANALYSIS

Application Number: 16252054
Application Type: Utility
Filing Date: 2019-01
Publication Date: 2019-05
Patent Classification: ["549", "292000"]

Abstract:
This disclosure describes biosynthesized compounds including anhydromevalonolactone and β-methyl-δ-valerolactone. This disclosure further describes biosynthetic methods for making these compounds. In some embodiments, the biosynthetic methods can include a combination of biosynthesis and chemical steps to produce β-methyl-δ-valerolactone. Finally, this disclosure described recombinant cells useful for the biosynthesis of these compounds.

Claim (Index 1):
A biosynthesized anhydromevalonolactone or anhydromevalonate compound.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 99.0
- Lexical Diversity: 1.51351
- Patent Class: 549.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['14783375', '15120037', '14625487', '13646562', '15279184']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6870629604545656
- 35 USC 102 Novelty (BERT): 0.5354115901188848
- Combined Prediction Score: 0.6718978234209976
- Mean Citation Score: 153.650278
- Max Citation Score: 350.93494
- Similarity Product: 228.6218511559844

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test